Eli Lilly to partner with Cipla, Lupin, Sun Pharma to manufacture, distribute Baricitinib in India
US drug-maker Eli Lilly, on May 10, announced that it had issued royalty-free, non-exclusive voluntary licenses to established Indian pharmaceutical manufacturers of... Read More
Top 10 Global Pharmaceutical Company in 2018
Posted on26 May 2019
Comments0
Case Study – A close look into Eli Lilly’s pricing strategy for Insulin Lispro injection in US market
Eli Lilly and Company’s has announced that its Insulin Lispro Injection is now available for order in pharmacies for people who use... Read More
Case Study: Lilly’ US FDA approval of Verzenio in combination with aromatase inhibitor to treat advanced breast cancer
Eli Lilly and Company has announced that the US Food and Drug Administration (FDA) has approved Verzenio (abemaciclib) in combination with an... Read More
AstraZeneca and Eli Lilly to co-develop Alzheimer’s disease (AD) drug which presently in phase 1 trial
AstraZeneca and Eli Lilly announced a worldwide agreement to co-develop MEDI1814, an antibody selective for amyloid-beta 42 (Aß42), which is currently in... Read More
New Indication Approval: Jardiance received USFDA’s New Cardiovascular Indication approval
Posted on07 Dec 2016
Comments0
The US Food and Drug Administration (FDA) approved a new indication for Jardiance (empagliflozin) tablets to reduce the risk of cardiovascular death... Read More
Technology Licensing Case Study: Peptiderm’s licensing of PDPS technology to Lilly
Technology transfer, also called transfer of technology (TOT), is the process of transferring skills, knowledge, technologies, methods of manufacturing, samples of manufacturing... Read More
Eli Lilly launched Trulicity (dulaglutide), once-a-week drug for type 2 diabetes, in India
Eli Lilly and Company (India) Pvt. Ltd. today announced the launch of its recently approved diabetes treatment Trulicity (dulaglutide) in India. Trulicity... Read More
Lilly and Merck’s Immuno-Oncology Collaboration Adding Abemaciclib and KEYTRUDA Combination Trial
Eli Lilly and Merck, known as MSD outside the United States and Canada, today announced another immuno-oncology collaboration that will evaluate abemaciclib... Read More
Novozyme Ranked 1 in among top 20 global biotech employers for 2015
Posted on03 Nov 2015
TagsAbbott, AbbVie, Alexion Pharmaceuticals, Bayer, Biocon, Biogen, Boehringer Ingelheim, Bristol-Myers Squibb, Celgene, Eli Lilly, Genentech, gilead, Merck KGaA, Moderna Therapeutics, Monsanto Company, Novozymes, Regeneron Pharmaceuticals Novo Nordisk, Roche—excluding Genentech, Top 10 Biotech company globally, vertex pharmaceuticals
Comments0
Novozymes has earned 1st rank globally on top biotechnology employers in the world as ranked by American Association for the Advancement of Science (AAAS).... Read More